End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 MYR | +1.69% | +7.14% | -29.41% |
Feb. 21 | Careplus Group Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Jan. 19 | Careplus Closes MYR2.7 Million Purchase of GVT | MT |
Valuation
Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 116.5 | 82.36 | 767.3 | 909.3 | 159 |
Enterprise Value (EV) 1 | 215 | 162.2 | 733.5 | 803.6 | 109.1 |
P/E ratio | -83.7 x | -14.3 x | 6.23 x | 4.19 x | -1.07 x |
Yield | - | - | - | 2.42% | - |
Capitalization / Revenue | 0.34 x | 0.23 x | 1.61 x | 1.3 x | 0.78 x |
EV / Revenue | 0.63 x | 0.44 x | 1.54 x | 1.15 x | 0.53 x |
EV / EBITDA | 6.94 x | 8.57 x | 5.3 x | 2.78 x | -2.18 x |
EV / FCF | -20.7 x | 3.51 x | 24 x | 30.7 x | - |
FCF Yield | -4.82% | 28.5% | 4.16% | 3.25% | - |
Price to Book | 1.2 x | 0.85 x | 2.98 x | 1.93 x | 0.59 x |
Nbr of stocks (in thousands) | 506,360 | 531,360 | 540,360 | 551,079 | 578,094 |
Reference price 2 | 0.2300 | 0.1550 | 1.420 | 1.650 | 0.2750 |
Announcement Date | 4/30/19 | 6/5/20 | 4/16/21 | 4/29/22 | 10/3/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 338.7 | 365.1 | 475.6 | 700.2 | 204.9 |
EBITDA 1 | 30.99 | 18.93 | 138.4 | 289.3 | -50.12 |
EBIT 1 | 10.15 | -1.55 | 122.7 | 267 | -74.55 |
Operating Margin | 3% | -0.42% | 25.79% | 38.14% | -36.38% |
Earnings before Tax (EBT) 1 | 6.093 | -7.932 | 148.5 | 276 | -153.5 |
Net income 1 | -1.422 | -5.751 | 122.5 | 220.9 | -147.2 |
Net margin | -0.42% | -1.58% | 25.75% | 31.55% | -71.81% |
EPS 2 | -0.002747 | -0.0108 | 0.2278 | 0.3941 | -0.2572 |
Free Cash Flow 1 | -10.37 | 46.26 | 30.52 | 26.15 | - |
FCF margin | -3.06% | 12.67% | 6.42% | 3.74% | - |
FCF Conversion (EBITDA) | - | 244.43% | 22.05% | 9.04% | - |
FCF Conversion (Net income) | - | - | 24.92% | 11.84% | - |
Dividend per Share | - | - | - | 0.0400 | - |
Announcement Date | 4/30/19 | 6/5/20 | 4/16/21 | 4/29/22 | 10/3/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | 98.6 | 79.9 | - | - | - |
Net Cash position 1 | - | - | 33.8 | 106 | 49.9 |
Leverage (Debt/EBITDA) | 3.18 x | 4.22 x | - | - | - |
Free Cash Flow 1 | -10.4 | 46.3 | 30.5 | 26.2 | - |
ROE (net income / shareholders' equity) | 2.8% | -6.65% | 68.2% | 59.1% | - |
ROA (Net income/ Total Assets) | 2.17% | -0.34% | 21.5% | 31.8% | - |
Assets 1 | -65.48 | 1,692 | 570.4 | 695 | - |
Book Value Per Share 2 | 0.1900 | 0.1800 | 0.4800 | 0.8500 | 0.4600 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0500 | 0.0700 | 0.0600 |
Capex 1 | 14 | 14.6 | 99 | 123 | 9.62 |
Capex / Sales | 4.14% | 4.01% | 20.82% | 17.58% | 4.69% |
Announcement Date | 4/30/19 | 6/5/20 | 4/16/21 | 4/29/22 | 10/3/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-29.41% | 43.44M | |
-30.75% | 3.07B | |
-15.97% | 2.52B | |
+18.11% | 2.47B | |
+7.78% | 2B | |
-9.47% | 1.91B | |
-0.56% | 1.47B | |
+2.24% | 1.33B | |
+24.32% | 1.19B | |
+3.86% | 1.14B |
- Stock Market
- Equities
- CAREPLS Stock
- Financials Careplus Group